nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

31.05.2018 | Reply

Reply to the letter

verfasst von: Hajira Ilyas, N. George Mikhaeel, Joel T. Dunn, Fareen Rahman, Henrik Møller, Daniel Smith, Sally F. Barrington

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 10/2018

Einloggen, um Zugang zu erhalten

Excerpt

We disagree with Laffon and Marthan that the prognostic value of baseline metabolic tumour volume (MTV) depends on the outlining method. One of our study aims was to compare the accuracy of various segmentation methods in predicting survival [1]. We found in our cohort of 147 consecutive patients with diffuse large B cell lymphoma (DLBCL) treated at a single institution that all methods (SUV ≥2.5, SUV ≥41% of SUVmax and SUV ≥mean liver uptake) predicted progression-free and overall survival with similar accuracy. Instead, it was the optimal cut-off values for predicting survival that were dependent on the method, which is an important distinction. …

Ilyas H, Mikhaeel NG, Dunn JT, Rahman F, Moller H, Smith D, et al. Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma. Eur J Nucl Med Mol Imaging. 2018. https://doi.org/10.1007/s00259-018-3953-z.

Biggi A, Gallamini A, Chauvie S, Hutchings M, Kostakoglu L, Gregianin M, et al. International validation study for interim PET in ABVD-treated, advanced-stage Hodgkin lymphoma: interpretation criteria and concordance rate among reviewers. J Nucl Med. 2013;54:683–90.CrossRefPubMed

Itti E, Meignan M, Berriolo-Riedinger A, Biggi A, Cashen AF, Vera P, et al. An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax. Eur J Nucl Med Mol Imaging. 2013;40:1312–20.CrossRefPubMed

Barrington SF, Kirkwood AA, Franceschetto A, Fulham MJ, Roberts TH, Almquist H, et al. PET-CT for staging and early response: results from the response-adapted therapy in advanced Hodgkin lymphoma study. Blood. 2016;127:1531–8.CrossRefPubMed

Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. European Association of Nuclear Medicine (EANM). FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328–54.CrossRefPubMed

Song MK, Yang DH, Lee GW, Lim SN, Shin S, Pak KJ, et al. High total metabolic tumor volume in PET/CT predicts worse prognosis in diffuse large B cell lymphoma patients with bone marrow involvement in rituximab era. Leuk Res. 2016;42:1–6.CrossRefPubMed

Song MK, Chung JS, Shin HJ, Lee SM, Lee SE, Lee HS, et al. Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvement. Ann Hematol. 2012;91:697–703.CrossRefPubMed

Gallamini A, Kostakoglu L. Metabolic tumor volume: we still need a platinum-standard metric. J Nucl Med. 2017;58:196–7.CrossRefPubMed

Titel: Reply to the letter
verfasst von: Hajira Ilyas
N. George Mikhaeel
Joel T. Dunn
Fareen Rahman
Henrik Møller
Daniel Smith
Sally F. Barrington
Publikationsdatum: 31.05.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 10/2018
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-018-4050-z

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Reply to the letter

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2018

Relationship between functional imaging and immunohistochemical markers and prediction of breast cancer subtype: a PET/MRI study

Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of 18F-Fluorocholine PET/CT

Tumor fragmentation estimated by volume surface ratio of tumors measured on 18F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphoma

Optimal method for measuring baseline metabolic tumor volume in DLBCL patients: are statistical agreements of SUV ≥2.5 satisfactory?

Molecular imaging and molecular diagnostics: two sides of the same coin?

18F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients